Evidence map›Paper›PMID 29500253›Full record

ArticleBritish journal of sports medicine2018

Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel.

Pascal Borry, Timothy Caulfield, Xavier Estivill, Sigmund Loland, Michael McNamee, Bartha Maria Knoppers, WADA Ethics Panel

Abstract readConsensus Statement
In one paragraph

Article in British journal of sports medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Legal and societal aspects of doping in sport].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pascal BorryDepartment of Public Health and Primary Care, University of Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-4931-9560
Timothy CaulfieldFaculty of Law and School of Public Health, University of Alberta, Edmonton, Canada.
Xavier EstivillGenetics Program, Sidra Medical and Research Centre, Doha, Qatar.
Sigmund LolandDepartment of Cultural and Social Studies, Norwegian School of Sport Sciences, Oslo, Norway.
Michael McNameeCollege of Engineering, Swansea University, Swansea, UK.
Bartha Maria KnoppersCentre of Genomics and Policy, McGill University, Montreal, Canada.
WADA Ethics Panel

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Through the widespread availability of location-identifying devices, geolocalisation could potentially be used to place athletes during out-of-competition testing. In light of this debate, the WADA Ethics Panel formulated the following questions: (1) should WADA and/or other sponsors consider funding such geolocalisation research projects?, (2) if successful, could they be proposed to athletes as a complementary device to Anti-Doping Administration and Management System to help geolocalisation and reduce the risk of missed tests? and (3) should such devices be offered on a voluntary basis, or is it conceivable that they would be made mandatory for all athletes in registered testing pools? In this position paper, the WADA Ethics Panel concludes that the use of geolocalisation could be useful in a research setting with the goal of understanding associations between genotype, phenotype and environment; however, it recognises that the use of geolocalisation as part of or as replacement of whereabouts rules is replete with ethical concerns. While benefits remain largely hypothetical and minimal, the potential invasion of privacy and the data security threats are real. Considering the impact on privacy, data security issues, the societal ramifications of offering such services and various pragmatic considerations, the WADA Ethics Panel concludes that at this time, the use of geolocalisation should neither be mandated as a tool for disclosing whereabouts nor implemented on a voluntary basis.

Indexed as

AthletesGeographic Information SystemsConfidentialityDoping in SportsHumansPrivacySubstance Abuse Detectiondoping

Identifiers

PMID29500253
PMCPMC5867440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.